Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.51 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.51 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.49 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.49 |
| ▸ | ARG2 | P78540 | 4/20 | 0.47 |
| ▸ | ARG1 | P05089 | 3/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.47 |
| ▸ | NOS1 | P29475 | 5/20 | 0.46 |
| ▸ | NOS2 | P35228 | 4/20 | 0.46 |
| ▸ | NOS3 | P29474 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4853808 | 0.91 | NOS1 (0.56) | GSRGRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL4853803 | 0.91 | NOS1 (0.56) | GSRGRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL516471 | 0.87 | GRIK1 (0.57) | GRIK1GRIK2SLC1A2SLC1A1DDAH1 | |
| SCHEMBL21335891 | 0.87 | GSR (0.48) | GSRGRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL16772166 | 0.84 | GSR (0.47) | GSRGRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL5967305 | 0.84 | GRIK1 (0.68) | GSRGRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL38735 | 0.84 | GRIK1 (0.68) | GSRGRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL2730539 | 0.84 | GRIK1 (0.68) | GSRGRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL5533751 | 0.84 | DDAH1 (0.53) | GSRDDAH1ARG2ARG1NOS1 | |
| SCHEMBL23531056 | 0.82 | GRIK1 (0.69) | GSRGRIK1GRIK2SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100093811-A1 | HIV PROTEASE INHIBITORS | MERCK SHARP & DOHME CORP. | 2010-04-15 | — | — | US | disclosed |
| WO-2009042094-A2 | HIV PROTEASE INHIBITORS | MERCK & CO., INC. (US) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009042093-A1 | HIV PROTEASE INHIBITORS | MERCK & CO., INC. (US) | 2009-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093811-A1 | HIV PROTEASE INHIBITORS | PRSS1, FURIN, SERPINB1 | GSR 3190/4885GRIK1 2003/4885GRIK2 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.